cas 59107-51-6|| where to buy 8-chloronaphthalen-1-amine

Nombre del producto:8-chloronaphthalen-1-amine

IUPAC Name:8-chloronaphthalen-1-amine

Unidad de embalaje	Stock disponible	Precio($)
CM141452-25g	in stock	ţřţ
CM141452-100g	in stock	ǎŽŽ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 59107-51-6 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :59107-51-6; Fórmula molecular:C10H8ClN; Punto de fusión:-; Código de sonrisas:ClC1=CC=CC2=CC=CC(N)=C12; Densidad:

: Número de catálogo:CM141452; Peso molecular:177.63; Punto de ebullición:; Nº Mdl:MFCD00465087; Almacenamiento:Keep in a tight container nitrogen protection，and store at ambient temperature，protect from light

: Naphthalenes; Naphthalene is a hydrocarbon produced by the distillation of coal tar and is an aromatic white crystalline substance. Naphthalene is the most abundant component in coal tar. It is used as an insect repellant and insect fumigant. The compound is used in the manufacture of celluloid, dyes, hydrogenated naphthalenes, oil fumes, smokeless powders and synthetic resins.

: Adagrasib; Jan. 10, 2024, EC approves KRAZATI (adagrasib) as a targeted treatment option for patients with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation.
Adagrasib is an orally available, potent, irreversible, small molecule inhibitor of KRAS G12C mutant isoform for the treatment of solid tumours harbouring KRAS G12C oncogenic driver mutation. Adagrasib covalently binds to the mutant cysteine in KRAS G12C and locks the mutant KRAS protein in its inactive state, thereby preventing downstream signalling without affecting wild-type KRAS protein.